Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Clinical trial NCT04138212 · RECRUITING

Trial details

NCT number: NCT04138212
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2019-10-22
Primary completion: 2023-12-21
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.